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Summary
Genetic linkage, genome mismatch scanning, and anal-
ysis of patients with alterations of chromosome 6 have
indicated that a major locus for development of the an-
terior segment of the eye, IRID1, is located at 6p25.
Abnormalities of this locus lead to glaucoma. FKHL7
(also called “FREAC3”), a member of the forkhead/
winged-helix transcription-factor family, has also been
mapped to 6p25. DNA sequencing of FKHL7 in five
IRID1 families and 16 sporadic patients with anterior-
segment defects revealed three mutations: a 10-bp de-
letion predicted to cause a frameshift and premature
protein truncation prior to the FKHL7 forkhead DNA-
binding domain, as well as two missense mutations of
conserved amino acids within the FKHL7 forkhead do-
main. Mf1, the murine homologue of FKHL7, is ex-
pressed in the developing brain, skeletal system, and eye,
consistent with FKHL7 having a role in ocular devel-
opment. However, mutational screening and genetic-
linkage analyses excluded FKHL7 from underlying the
anterior-segment disorders in two IRID1 families with
linkage to 6p25. Our findings demonstrate that, al-
though mutations of FKHL7 result in anterior-segment
defects and glaucoma in some patients, it is probable
that at least one more locus involved in the regulation
of eye development is also located at 6p25.
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Introduction
Glaucoma is a major worldwide cause of blindness and
is characterized by progressive degeneration of the optic
nerve, usually associated with increased intraocular pres-
sure (IOP). The Canadian National Institute for the
Blind has identified glaucoma and macular degeneration
as the two leading causes of blindness in Canada. Glau-
coma is the primary cause of blindness in Canadians of
African descent and is the second leading cause in Cau-
casians. It has been estimated that, by the year 2000,
there will be ∼67 million cases of glaucoma worldwide
and almost 6.7 million cases of blindness as a direct
result of the disease (Quigley 1996). More than 130,000
of these persons are estimated to become blind as a result
of this glaucoma. Blindness from glaucoma usually be-
gins with loss of peripheral vision. Central vision is often
maintained until the late stages. By the time the patient
notices visual loss, damage is advanced. In most cases,
vision loss could have been prevented had glaucoma
been detected and treated in time. Although glaucoma
is as common as high blood pressure and diabetes, the
general public lack of familiarity with it results in
thousands of cases of blindness annually, most of which
could have been prevented. The key to successful treat-
ment lies in detection of glaucoma before irreversible
optic-nerve damage has occurred.
Although a number of glaucoma genes have been
mapped (Raymond 1997), only two glaucoma loci
(GLC1A and GLC3A) have been cloned. A locus for
primary open-angle glaucoma (GLC1A) was first
mapped by genetic linkage analysis, in 1993, to markers
on chromosome 1q21-1q31 (Sheffield et al. 1993). Stone
and colleagues in early 1997 identified mutations in fam-
ilies with GLC1A in the TIGR/myocilin gene (Stone et
al. 1997), a gene known previously to encode a trabec-
ular meshwork protein postulated to have a role in the
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regulation of IOP (Nguyen et al. 1993). To date, se-
quencing of the TIGR/myocilin gene in glaucoma pa-
tients (including unselected patients from walk-in glau-
coma clinics) has indicated that ∼4% of primary
open-angle glaucoma patients have mutations in TIGR/
myocilin. GLC3A, underlying rare autosomal recessive
congenital glaucoma (OMIM 231300), has been
mapped to 2p21 in a group of 17 families (Sarfarazi et
al. 1995). Subsequently, mutations in the human cyto-
chrome P4501B1 gene were discovered in GLC3A-
linked families (Stoilov et al. 1997).
Anterior-segment dysgenesis, the incorrect formation
of the structures of the anterior segment of the eye, un-
derlies some cases of congenital glaucoma (Kaiser-Kup-
fer 1989). Recently, several clinically related autosomal
dominant disorders of anterior-segment formation that
result in glaucoma have been genetically colocalized to
chromosome 6p25. These disorders include iridogonio-
dysgenesis anomaly (IGDA; Mears et al. 1996; Graff et
al. 1997), Axenfeld-Rieger anomaly (ARA; Gould et al.
1997), familial glaucoma iridogoniodysplasia (FGI; Jor-
dan et al. 1997), and familial glaucoma with goniod-
ysgenesis (FGG; Morissette et al. 1997). The results of
genome mismatch–scanning studies have also indicated
that a locus for anterior-segment dysgenesis is located
at 6p25 (Mirzayans et al. 1997). Chromosomal altera-
tions of 6p25 have also been reported in patients with
a variety of clinical findings, including anterior-segment
malformations and congenital glaucoma (Peeden et al.
1983; Reid et al. 1983; Levin et al. 1986; Zurcher et al.
1990; Alashari et al. 1995; Nishimura et al. 1997). The
overlapping clinical presentations and colocalization of
these disorders suggests that a single locus called
“IRID1” (OMIM 601631), responsible for anterior-seg-
ment development and glaucoma, is located at 6p25.
The glaucoma that IRID1 patients develop is likely a
result of incorrect regulation of the outflow of aqueous
humor, because of the maldevelopment of the anterior
segment–angle structures. Therefore, the IRID1 locus is
predicted to have a role in human eye de-
velopment.
We report here the discovery of mutations in IRID1
patients in FKHL7, a member of the evolutionarily con-
served forkhead/winged-helix transcription-factor gene
family. Expression studies and the eye phenotype of
mouse embryos homozygous for null mutations of Mf1,
the murine homologue of FKHL7, are consistent with
a role for Mf1/FKHL7 in eye development. However,
mutation screening and genetic-linkage analyses have ex-
cluded FKHL7 from underlying the glaucoma and an-
terior segment–dysgenesis phenotypes in two of the
IRID1 families with linkage to 6p25. Mutations of
FKHL7 were found only in ARA patients, suggesting
that FKHL7 underlies only the ARA phenotype of
IRID1. It is probable that at least one additional locus
involved in eye development must be located at 6p25.
Subjects, Material, and Methods
Clinical Data
The clinical presentations within IRID1 families 1–5
have all been reported elsewhere. Families 1 and 2 were
originally diagnosed with IGDA (Pearce et al. 1983;
Mears et al. 1996), family 3 with ARA (Gould et al.
1997), family 4 with FGI (Jordan et al. 1997), and family
5 with FGG (Morissette et al. 1997). All five IRID1
families demonstrate phenotypic variability, but affected
individuals typically present with iris hypoplasia, iri-
docorneal angle defects (goniodysgenesis), and increased
IOP with subsequent risk of glaucoma. Affected indi-
viduals within IRID1 family 3 also had both a promi-
nent, anteriorly displaced Schwalbe’s line (posterior em-
bryotoxon) attached to peripheral iris strands bridging
the iridocorneal angle and displaced pupils (corectopia).
Sixteen unrelated individuals with anterior-segment dys-
genesis were also studied. The clinical findings in the five
IRID1 families and in the 16 additional individuals are
presented in table 1. The study and collection of blood
samples from all individuals included in the present re-
port were approved by the Research Ethics Board of the
Faculty of Medicine of the University of Alberta.
Polymorphic Markers
Novel polymorphisms were detected in exon 5 of the
NAD(P)H:quinone oxidoreductase-2 gene (NQO2) by
direct sequencing of PCR products amplified from key
recombinant branches of the IRID1 families. Primers for
exon 5 were as follows: forward, 5′-gcttcattccgaatcac-
cag-3′; reverse, 5′-gtcccctccctccaactatc-3′. Primers were
designed by use of Primer 3, available from the Primer3
Test Pre-Release (Whitehead Institute for Biomedical Re-
search) Website. Each of the two polymorphisms within
NQO2 exon 5 affects MspI sites, at positions 111 bp
and 188 bp of the 250-bp PCR product, generating a
four-allele polymorphic system.
Physical Mapping
The preliminary physical map for the 6p25 IRID1
region was obtained from the Whitehead Institute for
BioMedical Research Web site. The human bacterial ar-
tificial chromosome (BAC) library (Shizuya et al. 1992;
Kim et al. 1996) was screened by PCR with sequence-
tagged sites (STSs)/expressed sequence tags (ESTs)
mapped to the region, according to Research Genetics
protocols. Selected clones were FISH mapped to confirm
cytogenetic location and then were analyzed for STS
content to determine order and overlap between clones.
Table 1
Clinical Features of Families and Patients in the Present Study
ID NUMBER PHENOTYPE
CLINICAL FEATURE(S)a
REFERENCEOcular Nonocular
FAM1 IGDA Abnormal angle vascularity, glaucoma, goniodysgenesis,
iris hypoplasia
None Mears et al. (1996)
FAM2 IGDA Abnormal angle vascularity, glaucoma, goniodysgenesis,
iris hypoplasia
None Mears et al. (1996)
FAM3 ARA Corectopia, glaucoma, goniodsygenesis, iris hypoplasia,
iris strands, posterior embryotoxon
Deafness, heart anomalies Gould et al. (1997)
FAM4 Glaucoma, goniodsygenesis, iris hypoplasia, Peter
anomaly
None Jordan et al. (1997)
FAM5 FGG Glaucoma, goniodysgenesis, iris hypoplasia None Morissette et al. (1997)
UA patient 1 ARA Glaucoma, iris hypoplasia None Present study
UA patient 2 ARA Glaucoma, iris strands, posterior embryotoxin None Present study
UA patient 3 IGDA Glaucoma, goniodsygenesis, iris hypoplasia None Present study
UA patient 4 ARA Cataracts, glaucoma, goniodysgenesis, iris strands None Present study
UA patient 5 ARS Glaucoma, Rieger eye malformation, sclerocornea Dental anomalies Present study
UA patient 6 ARS Abnormal angle vascularity, glaucoma, iris hypoplasia,
iris strands
Bowel resection, dental anomalies, inguinal hernia Present study
UA patient 7 ARS Cataracts, glaucoma, iris hypoplasia Dental anomalies, mental retardation Present study
UA patient 8 Anterior-segment dysgenesis Cataracts, corectopia, iris hypoplasia, optic-nerve
hypoplasia
None Present study
UA patient 9 IGDA Cataracts, goniodysgenesis None Present study
UA patient 10 ARS Corectopia, glaucoma, iris strands, posterior
embryotoxin
Dental anomalies, maxillary hypoplasia Present study
UA patient 11 IGDA Glaucoma, goniodysgenesis None Present study
UA patient 12 ARS Cataracts, corectopia, glaucoma Dental anomalies, maxillary hypoplasia, psychiatric illness Present study
UA patient 13 IGDA Glaucoma, goniodysgenesis, iris hypoplasia None Present study
UA patient 14 ARS Corectopia, goniodysgenesis, glaucoma, iris hypoplasia,
iris strands
dental anomalies Present study
UA patient 15 ARA Abnormal angle vascularity, corneal irregularities, glau-
coma, iris strands
None Present study
UA patient 16 ARA Corectopia, glaucoma, goniodysgenesis, iris hypoplasia,
iris strands
None Present study
a Not every affected member of a family presented with all ocular or nonocular features listed for that family.
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Table 2
Primer Pairs Used in PCR Amplification of FKHL7
PRIMER-PAIR
DESIGNATION
PRIMER (NUCLEOTIDE POSITIONa)
(5′r3′)
PRODUCT
SIZE
(bp)Forward Reverse
A cccggactcggactcggc (93 to 76) ccgaggtagggcaccact (42 to 59) 152
B gtccagccccaactccct (21 to 38) cggctccttgaggtgc (567 to 582) 562
C gtccagccccaactccct (21 to 38) gcatggcggtgtagcc (106 to 121) 101
D ggctacaccgccatgc (106 to 121) actggtagatgccgttcagg (300 to 319) 214
E ggcgcttcaagaagaaggac (515 to 535) ctgaagccctggctatggt (908 to 926) 412
F aagatcgagagccccgac (766 to 783) cagaaggccggagctgag (982 to 999) 234
G accatagccagggcttcag (908 to 926) caggttgcagtggtaggtcc (1172 to 1191) 284
H gagctccctctacagctccc (1071 to 1090) gtgaccggaggcagagagta (1291 to 1310) 240
I caagccatgagcctgtacg (1192 to 1210) gggttcgatttagttcggct (1674 to 1693) 502
a Within the FKHL7 gene of the primer; numbering is as in fig. 2.
Sequence Scanning
Sequence scanning was performed on the BAC
RMC06B016. This BAC, with an insert of ∼150 kb, was
sheared randomly, and fragments of 2–3 kb were sub-
cloned into M13mp18 vector. Sequences were obtained
from 509 subclones by ABI 373 and 377 automated
sequencers and were assembled into contigs by Seqman
(DNASTAR). Contigs were searched for coding se-
quence by BLAST 2.0 against the National Center for
Biotechnology Information (GenBank) and dEST data-
bases. GRAIL 1.2 was used to predict coding sequence
not represented in existing databases.
Mutation Detection
Fragments were amplified from the single-exon
FKHL7 gene, by means of primers designed by Primer3.
FKHL7 sequence has been deposited in Genbank (ac-
cession number AF078096). FKHL7 primers are listed
in table 2. PCR reactions were performed with 20 ng of
DNA in a 25-ml volume containing 20 mM Tris-HCl
(pH 8.4 at 23C), 50 mM KCl, 1.5 mM MgCl2, 200 mM
each of dCTP, dTTP, dATP, and dGTP, and 60 ng of
each primer. Dimethyl sulfoxide (final concentration
10%) was added to PCR reactions to alleviate second-
ary-structure problems created by the very high GC con-
tent of FKHL7. Each reaction was overlaid with 40 ml
of light mineral oil to prevent evaporation. PCR speci-
ficity was increased through a “hot-start” step in which
samples were subjected to a denaturing step of 5 min at
95C, during which time 1 unit of Taq DNA polymerase
and sufficient H2O were added to produce a final total
PCR-reaction volume of 25 ml. A further 3-min dena-
turing step at 95C was followed by 35 cycles of de-
naturing at 94C for 30 s, annealing at 58C for 30 s,
and extension at 72C for 30 s, with a final elongation
step of 72C for 7 min. PCR products were purified with
QIAquick columns (QIAGEN) and then were directly
sequenced via 33-P cycle sequencing (Amersham).
Mutations were confirmed in affected individuals and
were screened for in 140 ethnically matched control
chromosomes by the following methods: the 10-bp de-
letion (del nt 92–103) was detected through analysis of
PCR products amplified with primer pair “C” on 1.5%
agarose/1.5% NuSieve electrophoretic gels. The G245C
mutation was detected through loss of an AluI site in
the PCR product amplified with primer set “D.” The
C261G mutation was detected through generation of a
BspHI site in the PCR product amplified with primer set
“B.”
The insertion polymorphisms (GGC375ins and
GGC347ins) were detected by sequencing in both pa-
tients and control individuals, by means of primer sets
“H” and “I,” respectively. PCR products using primer
sets “H” and “I,” containing the GGC375ins and
GGC347ins polymorphisms, respectively, were sepa-
rated on 6% denaturing polyacrylamide gels to obtain
allele frequencies.
Expression Analysis
Expression of FKHL7 was determined with com-
mercially available northern blots (Clontech), with
poly(A)-selected RNA from a variety of adult and fetal
tissues. To avoid cross-hybridization with other fork-
head-related genes, the probe for FKHL7 was selected
from the 3′ region (nucleotides 1192–1690). Hybridi-
zation and washes were performed according to the
manufacturer’s protocols. The human b-ACTIN control
probe, provided by the manufacturer, was used to equal-
ize loading differences. The methodologies of the ex-
pression studies using the Mf1lacZ allele of Mf1, the
mouse FKHL7 homologue, have been described in detail
by Kume et al. (1998).
Results
Genetic Refinement of the Location of the IRID1 Locus
Genetic linkage analysis was used to refine the location
of the IRID1 locus. Analyses of new polymorphic loci
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Figure 1 Genetic mapping of IRID1 gene(s): schematic presentation of chromosome 6, illustrating the genetic mapping of the IRID1
gene(s). Cumulative genetic distances (in cM) from the telomere are indicated on the left. The disease haplotypes segregating in each of the five
IRID1 families are labeled “H1”–“H5.” For each locus, alleles were numbered according to size, from smallest to largest. Key recombinant
individuals are identified at the top of the figure, with disease status indicated at the bottom. Square symbols indicate males, and circles indicate
females. Boxed regions indicate the portion of the disease-associated haplotype present in the recombinant individual; stippled boxes indicate
polymorphic loci for which haplotypes could not be unambiguously assigned. The location of the locus associated with anterior-segmentdysgenesis
and glaucoma in families 1 and 4 is indicated on the right.
that we generated (A. J. Mears and M. A. Walter, un-
published data), as well as the known 6p25 polymorphic
markers in five IRID1 families, were, overall, consistent
with the localization of IRID1 between D6S1600 and
polymorphisms in the NQO2 gene (fig. 1). However, one
unaffected individual (VIII:1 in IRID1 family 1) had an
apparent crossover event placing IRID1 distal to
D6S344 (fig. 1). This observation is inconsistent with
FKHL7 being a candidate gene for IRID1 in family 1
(see below). The IRID1 disease phenotype has been ob-
served to be a fully penetrant autosomal dominant trait
(Berg 1932; Weatherill and Hart 1969; Jerndal 1972;
Mears et al. 1996; Gould et al. 1997; Jordan et al. 1997).
Nevertheless, nonpenetrance of IRID1 in individual
VIII:1 in family 1 could not be formally ruled out
as a possible explanation of this apparent mapping
discrepancy.
FKHL7, a Candidate Gene Located in the IRID1
Critical Region
Twenty-nine BACs were obtained by screening a BAC
genomic library with known STSs and ESTs to physically
clone the IRID1 interval (A. J. Mears and M. A. Walter,
unpublished data). BAC RMC06B016 was found to
contain the distal flanking marker D6S344 and to test
positive with primers designed from published partial
sequence of FKHL7, a gene previously mapped to 6p25
(Larsson et al. 1995). FKHL7 is a member of the fork-
head transcription-factor gene family shown to be in-
volved in embryonic development, tissue-specific gene
expression, and oncogenesis (Shapiro et al. 1993; Pier-
rou et al. 1994; Sasaki and Hogan 1994; Larsson et al.
1995; Kaufmann and Knochel 1996).
The DNA sequence of ∼80% of BAC RMC06B016,
or ∼120 kb of sequence, was determined as a rapid
means of both characterizing FKHL7 and identifying
additional genes within the IRID1 critical region. The
sequence of the forkhead-related region of BAC
RMC06B016 was identical to the partial DNA sequence
of the FKHL7 gene (Larsson et al. 1995). Additional
sequence analysis revealed that FKHL7 has an intronless
open-reading frame of 1,659 bp and is predicted to en-
code a protein of 553 amino acids (fig. 2). Mf1, the
murine gene homologous to FKHL7, is also predicted
to encode a protein 553 amino acids in length and has
been mapped to mouse chromosome 13, in a region of
conserved synteny with human 6p25 (Mouse Genome
Informatics database). The human FKHL7 gene and the
mouse Mf1 gene share 89% of their nucleotide sequence
through the coding region, with the highest degree of
Figure 2 FKHL7, a member of the forkhead-domain family of transcription factors: nucleotide and predicted amino acid sequence of
FKHL7. The open reading frame is 1,659 bp in length, predicted to encode a 553-amino-acid protein. The forkhead domain, spanning amino
acids 69–178, is boxed. The best-predicted transcriptional start site, at position 526, is in boldface . The predicted TATA box, 25 bp farther
upstream, is boldface and underlined. The arrowheads indicate the two locations of the polymorphic GGC insertions. The three FKHL7mutations
detected in ARA patients are indicated by numerals “1”–“3.” The horizontal bars above the nucleotide sequence denote the affected nucleotides.
Mutation 1 is a 10-bp deletion of nucleotides 93–102, predicted to result in a frameshift coding alteration and premature protein truncation.
Mutation 2 is G245C, resulting in the amino acid change Ser82Thr. Mutation 3 is C261G, resulting in the amino acid change Ile87Met.
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Figure 3 Sequence analysis of mutations of FKHL7: autoradi-
ographs showing sequence analysis of the mutations identified in
IRID1 family 3 and in two sporadic patients with anterior-segment
dysgenesis and glaucoma. PCR products were amplified from DNA
samples from patients and were directly sequenced. Normal sequences
are shown on the left; sequences from affected individuals are shown
on the right. In each case, the reverse-primer sequence is shown, with
the four lanes representing, from left to right, bases G, A, T, and C.
The positions of the mutations are shown on the right. Predicted effects
of FKHL7 mutations are indicated on the far right.
Figure 4 Segregation analysis of the G245C (Ser82Thr) muta-
tion in IRID1 family 3. Symbols designating affected and unaffected
individuals and males and females are as in fig. 1. The 214-bp FKHL7
amplification product generated from FKHL7 primer pair “D” (table
2) is cleaved by AluI into 138- and 76-bp fragments in unaffected
individuals. The G245C mutation abolishes this AluI site in affected
individuals, and the resultant 214-bp allele segregates with the anterior
segment–dysgenesis phenotype in IRID1 family 3. The “normal” AluI
cleavage products present in affected individuals are generated from
the nonmutated FKHL7 allele in these individuals.
identity (96%) seen over the 330 nucleotides of the fork-
head domains. Overall, identity at the protein level was
92%, with 100% identity throughout the forkhead
DNA-binding region. By use of an algorithm from the
Promoter Prediction by Neural Network Website, a tran-
scription start site has been predicted to occur at position
526, with aTATA box predicted 25 bp farther up-
stream (fig. 2). This predicted transcription start site is
32 bp upstream of the longest Mf1 cDNA clone and is
conserved between mice and humans.
FKHL7 Mutations in Patients with Anterior Segment
Dysgenesis and Glaucoma
FKHL7 was screened for mutations by direct DNA
sequencing of PCR products from affected individuals
of the five IRID1 families with linkage to 6p25 poly-
morphic loci and in 16 additional unrelated individuals
with anterior-segment dysgenesis (table 1). Five nucle-
otide alterations in FKHL7 were found (fig. 2). A 10-
bp deletion, located between the initiation codon and
the FKHL7 forkhead domain, was found in an individ-
ual with ARA and glaucoma (patient 1; fig. 3). This
alteration is predicted to result in a frameshift mutation
and premature stop after 10 amino acids and was not
observed in 1124 normal chromosomes. A second al-
teration, a GrC transversion at nucleotide position 245,
predicted to result in a Ser82Thr mutation at the very
beginning of helix 1 of the FKHL7 forkhead domain,
was identified in IRID1 family 3 (originally diagnosed
with ARA; fig. 3). This G245C mutation abolishes an
AluI restriction-enzyme site and segregates with the an-
terior-segment dysgenesis/glaucoma phenotype in all af-
fected members in family 3 (fig. 4). This G245C mu-
tation was not observed in 140 normal chromosomes.
This amino acid position is invariantly a serine in 180
forkhead-family genes over a range of species, from yeast
to humans (Kaufmann and Knochel 1996). This serine
is immediately adjacent to a conserved tyrosine amino
acid residue that makes a phosphate-based contact with
DNA (Clark et al. 1993). The distantly related QRF1
(glutamine Q-rich factor 1) (Li and Tucker 1993) gene
has a threonine instead of a serine residue at this position
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Figure 5 Northern blot analysis of FKHL7: expression in human tissues. A commercial multiple-tissue northern blot was hybridized with
a FKHL7 probe (upper panels) and with a b-ACTIN control probe (lower panels). The 4.5-kb FKHL7 transcript is indicated by an arrow, on
the right. A 4.0-kb alternative FKHL7 transcript is also present in fetal kidney RNA and is indicated by an arrowhead.
at the start of helix 1. However, since the QRF1 DNA-
binding domain is only 84 amino acids in length, com-
pared with 110 amino acids for all other known fork-
head proteins, QRF1 could well fall outside the forkhead
family. Consistent with this notion, QRF1 appears to
bind DNA differently from the manner that is predicted
for forkhead proteins (Clark et al. 1993; Li and Tucker
1993) and therefore may not require a serine at this
position. Site-directed mutagenesis of both this serine
and the two flanking tyrosines in the related forkhead
gene HNF-3g abolished DNA-binding activity (Clevid-
ence et al. 1993). The third mutation, a CrG transver-
sion at nucleotide position 261, which would result in
the missense mutation Ile87Met in helix 1 of the FKHL7
forkhead domain (fig. 2), was identified in an individual
diagnosed with ARA and glaucoma (patient 2; fig. 3).
This C261G mutation creates a BspHI restriction-en-
zyme site. This mutation was not observed in 144 nor-
mal chromosomes. This position within helix 1 is an
isoleucine in 188% of forkhead genes and has never been
reported as a methionine (Kaufmann and Knochel
1996). Interestingly, as well as occurring within the
putative DNA-binding domain of FKHL7, both the
Ser82Thr and the Ile87Met missense mutations occur
within a conserved region proposed to act as a nuclear-
localization signal necessary and sufficient for nuclear
targeting of the related forkhead-family gene, HNF-3b
(Qian and Costa 1995).
Two alterations, GGC375ins and GGC447ins, each
involving the insertion of an extra GGC triplet in two
separate GGC repeats within the FKHL7 coding region
(fig. 2), were found both in patients and in control in-
dividuals. These alterations are therefore presumed to
be non-IRID1–associated polymorphisms of FKHL7.
GGC375ins has two alleles; 77% of 94 normal control
chromosomes are observed to carry the GGC6 allele,
23% the GGC7 allele. The GGC447ins polymorphism
also has two alleles; 83% of 110 normal control chro-
mosomes are observed to carry the GGC7 allele, 17%
the GGC8 allele. Although the GGC repeat associated
with the human GGC375ins polymorphism is conserved
in the mouse Mf1 sequence, there is no evidence that
the murine GGC repeat is polymorphic.
FKHL7 Expression Studies
A 4.5-kb FKHL7 mRNA transcript was detected by
northern blot analyses in multiple adult and fetal human
tissues. Highest expression of FKHL7 was observed in
adult kidney, heart, peripheral blood leukocytes, and
prostate and in fetal kidney (fig. 5). An alternative tran-
script of size 4.0 kb was also detected in fetal kidney,
possibly suggesting use of an alternate promoter or poly-
adenylation site in this tissue. This FKHL7 fetal-kidney
alternative transcript has also been observed in previous
studies (Pierrou et al. 1994; Nishimura et al. 1998). PCR
analyses indicated that FKHL7 was also expressed in
human fetal craniofacial RNA and in the adult iris (data
not shown).
The murine Mf1 gene was inactivated by homologous
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recombination in embryonic stem cells in which se-
quences corresponding to amino acids 50–553 and the
3′ UTR of theMf1 gene were replaced by a lacZ/PGKneor
cassette in frame with the first AUG (Kume et al. 1998).
Mf1lacZ-homozygous mice developed severe eye anom-
alies and hydrocephalus (Kume et al. 1998). LacZ ac-
tivity was analyzed in Mf1lacZ-homozygous and -hetero-
zygous embryos to analyze Mf1 expression in more
detail. In the eye of 14.5 dpc heterozygous and homo-
zygous mouse embryos, lacZ staining was abundant in
the periocular mesenchyme and in the developing lids
and anterior segment of the eye (fig. 6). Mf1 is widely
expressed in mesenchyme tissues and in the developing
eye (Kume et al. 1998). Both the expression pattern of
the murine homologue of the FKHL7 gene and the fact
that Mf1-homozygous-null mutant mouse embryos have
severe eye findings in addition to hydrocephalus are
strongly consistent with the hypothesis that FKHL7 has
a role in eye development. The relatively less severe
anomalies observed in human IRID1 patients compared
with the Mf1 homozygous mutant mice presumably re-
sult from the fact that IRID1 patients are heterozygotes
and thus retain a single functional copy of the FKHL7
gene.
IRID1: Genetically Heterogeneous
Surprisingly, complete DNA sequencing of the
FKHL7-gene coding region in affected individuals of
families 1, 2, 4, and 5 failed to identify any additional
IRID1-associated mutations of FKHL7. Although the
high GC content of FKHL7 makes it remotely possible
that a FKHL7 mutation could be missed because of GC
compressions despite our efforts to resolve the FKHL7
sequence, it is very unlikely that mutations in all four
families would be missed. In addition, analysis of the
GGC447ins polymorphism in IRID1 family 4 geneti-
cally excluded the FKHL7 gene from underlying the
IRID1 phenotype in this family (fig. 1). Since the
GGC447ins polymorphism is only 1,341 bp from the
translation start, and since FKHL7 does not contain any
introns, it is exceedingly unlikely that an intragenic
crossover event could explain these findings. Instead, the
recombination event in VIII:24 of IRID1 family 4, to-
gether with the recombination event within unaffected
individual VIII:1 in IRID1 family 1, discussed above,
is strongly consistent with the localization, between
D6S1600 and D6S344, of a second locus associated with
anterior-segment dysgenesis and glaucoma (fig. 1).
Discussion
There is increasing genetic evidence that members of
the forkhead/winged-helix gene family play key roles in
embryonic development, cell-fate determination, and tis-
sue-specific gene expression, in both vertebrates and in-
vertebrates (Kaufmann and Knochel 1996). For exam-
ple, the prototypic forkhead (fkh) gene of Drosophila
regulates fore and hindgut development and morpho-
genesis and controls the localized expression of signaling
genes such as wingless (wg), hedgehog (hh), and deca-
pentaplegic (dpp) (Weigel et al. 1989; Hoch and Pank-
ratz 1996). Aspects of this role of fkh in gut development
appear to have been conserved during evolution (Rob-
erts et al. 1995). In mammals, mutation of the winged-
helix nude (whn) forkhead gene disrupts normal hair
growth and thymus development in nude mice and rats
(Nehls et al. 1994), whereas mice with loss-of-function
mutations of the forkhead gene HNF-3b exhibit defects
in notochord and gut formation (Ang and Rossant 1994;
Weinstein et al. 1994).
Forkhead-family genes have also been implicated in
tumorigenesis. The forkhead-related avian sarcoma virus
31 gene, qin, determines the transforming ability of the
retrovirus (Li and Vogt 1993). Translocations between
chromosomes 2 and 13 that fuse the PAX3 gene to the
forkhead gene FKHR have been found in pediatric al-
veolar rhabdomyosarcoma (Galili et al. 1993). Fusion
of the zinc-finger transcription gene HTRX1 on chro-
mosome 11 to the AFX1 forkhead gene on the X chro-
mosome have also been found in acute lymphocytic leu-
kemia patients with t(X,11) translocations (Parry et al.
1994).
While this study was under review, FKHL7 was re-
ported to be (a) located !20 kb from the 6p25 trans-
location breakpoint in an individual with an unbalanced,
t(2,6)(q35, p25) karyotype who presented with a variety
of clinical findings including glaucoma and (b) mutated
in four small families with anterior segment–dysgenesis
phenotypes (Nishimura et al. 1998). Our finding of
FKHL7 mutations in three patients with ocular defects
confirms these findings and implicates FKHL7 in ARA.
The 10-bp deletion of the FKHL7 gene is predicted to
result in a frameshift and truncated protein, whereas the
two missense mutations of highly conserved amino acids
could impair DNA binding and, possibly, nuclear lo-
calization of the FKHL7 protein. Although northern
blot–expression studies have found that FKHL7 is
widely expressed in adult and fetal tissues, the expression
of Mf1 in the mesenchyme of the developing eye is very
similar to that observed for the RIEG/PITX2 gene.
RIEG mutations result in Axenfeld-Rieger syndrome
(ARS), an autosomal dominant disorder presenting with
ARA-like ocular findings in addition to abnormalities of
the teeth, jaw, and umbilicus (Semina et al. 1996). The
three presumed inactivating mutations of FKHL7 and
the expression pattern of Mf1 in the developing eye are
consistent with haploinsufficiency of FKHL7 as under-
lying the autosomal dominant glaucoma and anterior-
segment dysgenesis in our ARA patients. Interestingly,
Figure 6 Expression studies of the FKHL7 mouse homologue Mf1. A Mf1 knockout mouse was generated by homologous recombination in embryonic stem cells in which sequences corresponding
to amino acids 50–553 and the 3′ UTR of the Mf1 gene were replaced by a lacZ/PGKneor cassette in frame with the first AUG (Kume et al. 1998). Mf1 expression in Mf1lacZ/ (/) and Mf1lacZ/
Mf1lacZ (/) embryos are indicated by the lacZ staining observed in photographs of sections of the developing eye in 14.5 dpc mice. The boxed regions in panels a and b are shown magnified in
panels c and d, respectively. Blue-stained tissue indicates regions of lacZ expression, corresponding to abundant Mf1 expression in the periocular mesenchyme, developing lids, and anterior segment.
1326 Am. J. Hum. Genet. 63:1316–1328, 1998
aniridia (i.e., partial to complete absence of the iris plus
abnormalities of the cornea, lens, and retina) and ARS,
both of which are autosomal dominant anterior-segment
malformations, also result from haploinsufficiency of the
PAX6 and RIEG transcription factors, respectively (Gla-
ser et al. 1992; Jordan et al. 1992; Hanson et al. 1993;
Semina et al. 1996). Anterior-segment formation must
therefore be under extremely stringent transcriptional
control.
Interestingly, all three mutations found here in the
FKHL7 gene occurred in patients originally diagnosed
with the ARA form of IRID1. The four additional
FKHL7 mutations recently reported by Nishimura et al.
(1998) also occurred in ARA individuals. To date, only
20%–30% of ARA/ARS patients have been found to
have mutations in the RIEG gene at chromosome 4q25
(S. Kulak and M. A. Walter, unpublished data). A sig-
nificant portion of ARS patients might therefore have
mutations of FKHL7 instead. ARS type 2 (RIEG2; an-
terior-segment anomalies plus nonocular features) has
been mapped to 13q14 (Phillips et al. 1996), the location
of the forkhead gene, FKHR. This gene must therefore
be considered an excellent candidate for RIEG2.
Mutational screening, however, excluded FKHL7
from underlying the anterior-segment disorders in four
families with glaucoma and anterior-segment dysgenesis
linked to 6p25. Genetic-linkage analyses using a GGC
trinucleotide–repeat polymorphism found within both
the FKHL7 coding region (fig. 2) and nearby polymor-
phic loci also excluded the FKHL7 gene in two of these
families (fig. 1). Interestingly, these four families—IRID1
families 1, 2, 4, and 5were originally diagnosed with
IGDA, IGDA, FGI, and FGG, respectively. The FKHL7
mutations that we found occurred in a family and in
two sporadic patients all originally diagnosed with ARA.
Although all these autosomal dominant disorders in-
clude glaucoma, iris hypoplasia, and anterior-angle de-
fects, ARA patients additionally present with a promi-
nent, anteriorly displaced Schwalbe’s line attached to
peripheral iris strands bridging the iridocorneal angle
and displaced pupils, features not typically seen in
IGDA, FGI, or FGG. The four remaining IRID1 families
might thus be phenotypically as well as genetically dis-
tinct from the ARA family and patients found to carry
FKHL7 mutations. Precluding intragenic crossover in
these families and the unlikely possibility that mutations
of noncoding portions of FKHL7 underlying IRID1 in
all four remaining glaucoma and anterior segment–
dysgenesis families, at least one additional locus involved
in the regulation of eye development must be located at
6p25.
Note added in proof.—After this article was accepted
for publication, additional information came to our at-
tention, indicating that mice heterozygous for an inac-
tivating allele ofMf1 display anterior-segment anomalies
including an absent or small Schlemm’s canal and hy-
poplastic trabecular meshwork (S. John, personal com-
munication), strongly supporting the hypothesis that
FKHL7/Mf1 has a significant role in eye development.
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